SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-098077
Filing Date
2010-04-29
Accepted
2010-04-29 09:12:28
Documents
6
Period of Report
2010-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 21616
2 OPINION OF COOLEY LLP dex51.htm EX-5.1 7133
3 SALES AGREEMENT, DATED APRIL 29, 2010 dex101.htm EX-10.1 162506
4 PRESS RELEASE dex991.htm EX-99.1 63034
5 GRAPHIC g80100g17z30.jpg GRAPHIC 7708
6 GRAPHIC g80100g38l46.jpg GRAPHIC 13395
  Complete submission text file 0001193125-10-098077.txt   285412
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 10779021
SIC: 2834 Pharmaceutical Preparations